A retrospective review of adenovirus infections at Texas Children's Hospital during 1990 -1996 was performed to evaluate the epidemiology, clinical course, management, and outcome of disseminated adenovirus disease (DAD) in children. DAD with multiorgan involvement occurred in 11 (2.5%) of 440 adenovirus-infected patients. Six (54%) of the 11 were immunocompromised and 5 (45%) were immunocompetent. Mortality was 83% among the immunodeficient, 60% in the immunocompetent, and 73% overall. Two (28%) of the 7 patients receiving immunoglobulins with or without antivirals and 3 (75%) of the 4 not treated died of DAD. DAD was caused by particular serotypes (3, 5, and 7) and occurred at a younger age in immunocompetent children. Viremia and prolonged viral excretion were more common in the immunocompromised. Clinical features and outcome were similar in both groups. Prospective studies addressing the use of new antiviral agents, combination antiviral therapy, and preventive strategies are necessary to determine the optimal therapeutic approach for patients with DAD.
Adenovirus infections occur worldwide in the form of epicome of DAD in immunocompetent and immunocompromised pediatric hosts, to review the literature on DAD, and to discuss demic, endemic, or sporadic disease, causing 2%-7% of respiratory tract infections in children in the first 5 years of life [1- current management and therapeutic options. 4]. With a tendency to cause lower respiratory tract disease, adenoviruses are responsible for 5%-11% of cases of viral pneuMethods monia and bronchiolitis in infants and children [5] [6] [7] [8] . The attack rate is higher in the very young and in those with environmental
Patients. We retrospectively reviewed the hospital records risk factors such as daycare attendance, overcrowding, and poor of all patients with positive adenovirus cultures at Texas Chilsocioeconomic status. Host factors such as malnutrition, anatomic dren's Hospital (Houston) between January 1990 and Decemabnormalities, metabolic or genetic disease, chronic heart or lung ber 1996. Patients were identified through the Diagnostic Viroldisease, and immunologic deficiencies contribute to the severity ogy Laboratory database. Approval to conduct a retrospective of adenovirus disease [9, 10] .
chart review was obtained from the Baylor College of Medicine Disseminated adenovirus disease (DAD) in children and Institutional Review Board and from each patient's physician. adults with AIDS or malignancies [11 -15] and in bone marrow Data, collected on a standardized form, included demographics, or solid organ transplant recipients [16 -21] is described with presence of underlying illnesses, clinical features of DAD, perincreasing frequency. In most series, pediatric patients are more tinent laboratory data, treatment, and outcome. likely to develop adenovirus disease than adults. Disseminated
Virology. Since 1989, the Diagnostic Virology Laboratory disease also has been described as occurring in neonates [22 - has performed adenovirus isolation and identification from 27] and in immunocompetent children in association with viral multiple clinical specimens according to standard collection infections that induce a temporary suppression of cell-mediated and processing techniques. Four different tissue culture cell immunity [28 -31] . DAD rarely occurs in previously healthy lines (human foreskin fibroblast, HEp2, RhMK, and A549) immunocompetent children [32 -35] .
were used for specimen inoculation. Preliminary identification We present a series of pediatric patients with DAD that by characteristic cytopathic effect was confirmed by indirect includes several previously healthy children. The objective of immunofluorescent antibody assays (Bartels, Issaquah, WA). this report is to describe the clinical manifestations and outIdentification of the adenovirus serotype of one of each patient's isolates was performed by a modified microneutralization assay with reference type -specific antisera (ATCC, Rockville, MD) to adenovirus types 1 -7 and 11, as previously cultures of blood or organ tissue specimens were positive for child with primary immunodeficiency (case 11) had prolonged hospitalizations (median, 73.5 days; range, 37-100 days) followadenovirus. The severity of DAD was assessed at the time of presentation on the basis of the multiple organ system failure ing acquisition of adenovirus infection. This group of patients developed fever, pneumonia with respiratory failure, gastroenteri-(MOSF) score, as described by Wilkinson et al. [38] . The casefatality rate was defined as the number of DAD-associated tis, shock, and severe gastrointestinal hemorrhage. Symptoms attributable to adenovirus disease were noted at deaths occurring between 1990 and 1996, divided by the number of diagnoses of DAD during the same period.
an manifested by altered mental status and seizures. Other clinical features suggestive of adenovirus infection were diarrhea, conRecords were available for review for 440 patients. Eleven (2.5%) of these patients developed DAD (table 1) . DAD ocjunctivitis, hematuria, and exanthem. Overall, the duration of illness, the average number of organs involved, and the severity curred in 3 (1.1%) of 264 children without underlying illnesses, in 6 (12.5%) of 48 immunocompromised patients, and 2 (1.5%) of disease (as assessed by MOSF [multiple-organ-system failure] score) were not significantly different in these patients (table 2) . of 128 children with other underlying chronic conditions. From 1990 to 1996, the incidence of DAD was zero to 7% per year.
Virology. Adenovirus serotypes 3, 5, and 7 caused DAD in immunocompetent children. One was not typeable by our Most cases (54%) occurred in March or April.
Demographics. Six patients with DAD (55%) had underlyreference panel of adenovirus serotypes 1 -7 or 11. Serotypes 1 and 2 were the cause of DAD in immunocompromised paing immunodeficiencies, 3 (50%) were liver transplant recipients, 2 (33%) had AIDS, and 1 (17%) had nonspecified primary tients. In all patients, adenovirus was isolated mainly from respiratory and grastrointestinal secretions (table 2) . immunodeficiency. Five patients (45%) were considered immunocompetent, and three were previously healthy. One had Although blood viral cultures were performed for all, viremia was documented only in two patients (cases 8 and 9), after 1 CHARGE syndrome (bilateral colobomas, congenital heart disease [i.e., corrected atrioventricular canal], growth retardation, week of illness. In contrast, viremia was present in all immunocompromised children (P Å .026). Viral shedding in respiratory cleft palate, ear anomalies, and deafness), and one was born at 28 weeks' gestation and had mild bronchopulmonary dysplasia.
or gastrointestinal secretions was prolonged in this group, with an average duration of 26.6 days (range, 24 -33 days) Laboratory evaluation failed to provide evidence of immunodeficiencies or inborn errors of metabolism in these children.
(P Å .024). Patients 6 and 10 had clinical and virological evidence of adenovirus hepatitis before death, but autopsy failed to reveal The patients' median age was 21 months, but immunocompetent children were younger (median, 11 months) (P Å .039).
active viral replication in the liver at the time of death. DAD outcome. The mortality rate was 83% among the The numbers of male and female patients and of white, black, and hispanic patients were similar (table 2) . immunodeficient patients, 60% among the immunocompetent patients, and 73% overall. DAD was the cause of death (conClinical features of DAD in children. All adenovirus infections were acquired in the community, except those of one immufirmed by autopsy) in five (45%) of 11 cases. The case-fatality rate was 60% (3 of 5) among immunocompetent children and nocompetent child (case 8) and two children with AIDS (cases 2 and 3). These patients developed a short (2-4 day) initial 50% (3 of 6) among the immunocompromised. One death of an immunodeficient child was caused by polymicrobial sepsis illness characterized by cough, congestion, rhinorrhea, and fever, which progressed to lower respiratory tract disease and DAD and that of two others by severe gastrointestinal hemorrhage, with adenovirus contributing to their morbidity and death. Conwithin 1 week. Two patients (cases 4 and 5) presented in cardiopulmonary arrest due to mucopurulent obstruction of the trachea current bacterial infections were more common in immunodeficient patients (table 2) . and apnea. Liver transplant recipients (cases 1, 6, and 10) and a / 9c5b$$no09
10-14-98 10:44:36 cida UC: CID . The onset of illness is usually acute, characterized by ment of patients with DAD was supportive care. Seven different fever, coryza, and severe pneumonia. Extrapulmonary manifesantiviral regimens were used for seven patients when adenovitations include meningoencephalitis, myocarditis, nephritis, rus infection was suspected or diagnosed. These included intrahepatitis, gastroenteritis, intravascular coagulopathy, conjunctivenous immunoglobulin alone or in combination with ribavirin vitis, and exanthem [2, 10, 32, 33, 41 -43] . (administered by inhalation, intravenously, or both), ganIn this series, DAD was characterized by severe pulmonary ciclovir, or acyclovir (table 1) . Immunoglobulin was adminisdisease, multiple-organ-system involvement, and death associtered early in the course of the disease and periodically thereafated with or directly attributed to adenovirus in 50% -83% of ter, in total doses varying between 1 g/kg and 8.5 g/kg.
the patients. Similar case-fatality rates have been reported for Intravenous ribavirin was given (in cases 9, 10, and 11) neonates, patients with impaired cellular immunity, and (rarely) according to an experimental/compassionate-use protocol appreviously healthy children [23, 24, 41, 43] . Immunocompetent proved by the institutional review board. A loading dose of 33 patients predominantly had respiratory tract involvement and mg/kg was followed by 16 mg/kg given in four doses for 4 complications, including severe pneumonia, pneumothorax, days, and 8 mg/kg divided in three doses for 3 days or longer, and pleural effusions. Immunocompromised patients, particuaccording to clinical response. DAD was the cause of death larly liver transplant recipients, had more significant gastroin-(confirmed by autopsy) for two (28%) of the seven patients testinal tract disease, including hepatitis, pancreatitis, and gastreated. In contrast, DAD was the cause of death for three trointestinal hemorrhage. Similar features of adenovirus (75%) of four of those patients who did not receive any form infection after liver transplantation in children have been reof antiviral treatment.
ported before [18, 19] . Although the lungs are commonly afDiscussion fected in all cases, it is likely that the primary site of disease Since their initial description in the 1950s, adenoviruses have in immunocompromised patients varies according to their underlying conditions. been known as a cause of common childhood respiratory ill-/ 9c5b$$no09
10-14-98 10:44:36 cida UC: CID factors for DAD in two of these patients.
Fibrinous pleuritis 2 2
There is no evidence of a higher predisposition to viral infec- 24] , usually secretions were significantly more common and prolonged in immunocompromised patients. Adenovirus excretion may conin combination with immunoglobulins and aggressive supportive care. Ribavirin appears to be more widely used, because tinue intermittently for several months after infection [4] ; therefore, the adherence to standard infection control practices is of evidence of in vitro inhibition of certain serotypes of adenovirus [57] . crucial in these cases. Nosocomial outbreaks can be associated with mortality rates of up to 91% and may be difficult to control Success rates seem to vary according to the type of underlying conditions and the severity of the disease. There are case [27, 43] .
DAD in immunocompetent patients is caused by specific reports of recovery from localized adenovirus disease such as hemorrhagic cystitis, pneumonia, gastroenteritis, and febrile serotypes, including adenovirus serotypes 3, 7, and 21, usually during epidemics [10, 33, 34] . In this series, immunocompetent illness [52 -55] , but the outcome has been poor despite antiviral therapy for patients with neonatal and disseminated disease children developed community-acquired adenovirus infections with serotypes 3, 5, and 7. Serotypes 3 and 7 are particularly [22 -24, 51 ]. These regimens, in association with supportive modalities such as extracorporeal membrane oxygenation, may pathogenic strains that cause disseminated, often fatal disease in previously healthy children [44 -46] . They are also more have been successful in neonates [22, 24] . The effect of antiviral therapy on the outcome and clinical likely to cause CNS disease, with encephalopathy and seizures [33, 47] .
response are difficult to assess retrospectively. Clinical im-/ 9c5b$$no09 10-14-98 10:44:36 cida UC: CID
